跳至主要内容
临床试验/NCT04649788
NCT04649788已完成不适用

Prospective Randomized Comparison of Efficacy and Safety of Ultrasound-guided Axillary Vein Access Versus Cephalic Venous Cutdown for Implantation of Cardiac Electronic Devices

Hospices Civils de Lyon2 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2020年7月17日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
200
试验地点
2
主要终点
Success of venous access

研究概览

简要总结

Venous access is a fundamental step in lead insertion for endovenous cardiac implantable electronic devices (CIED). Cephalic vein cutdown is the most widely used technique in Europe. Ultrasound-guided axillary vein access is a promising alternative but there is a lack of clinical evidence supporting this technique.

The purpose of this study is to compare the efficacy and safety of ultrasound-guided axillary vein access versus cephalic venous cutdown for implantation of endovenous CIED.

Half of patients is implanted using an ultrasound-guided axillary vein puncture. The other half is implanted using a cephalic vein cutdown. After venous access is achieved, implantation procedure is identical in the two arms.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years or older
  • Indication for endovenous pacemaker or cardioverter-defibrillator (single or double room)

排除标准

  • History of previously implanted endocardial lead
  • Indication for cardiac resynchronization therapy
  • Impossibility of venous access
  • Unable/unwilling to provide informed consent
  • Pregnant or breastfeeding woman
  • Participating in another clinical study which can interfere with this study

结局指标

主要结局

Success of venous access

时间窗: Intervention time (day 0)

This outcome is measured by the operator during the intervention. It is the ability to successfully cannulate the vein and have all needed guidewire in the right atrium using the assigned venous access technique. The outcome is a binary value: success or failure.

次要结局

  • X-Ray exposure(Intervention time (day 0))
  • Cardiac implantable electronic device (CIED) related infection(Month 3)
  • Procedure duration(Intervention time (day 0))
  • Fluoroscopy time(Intervention time (day 0))
  • Time to venous access(Intervention time (day 0))
  • Complication(Intervention time (day 0))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验